Here’s a roundup of some of Wednesday’s major pharmaceutical news: An FDA panel gave Human Genome Sciences a boost with a thumbs-up for its lupus drug, Benlysta; Merck’s experimental heart drug appears to work well without side effects; and Novartis announced its plans for long-term growth.
Continue reading Pharmaceutical News Roundup: Human Genome, Merck, Novartis
Pharmaceutical News Roundup: Human Genome, Merck, Novartis originally appeared on DailyFinance on Wed, 17 Nov 2010 15:57:00.
Filed Under: Company News, Health Care, Merck, Human Genome, GlaxoSmithKline, Novartis, Stocks in the News